|
ATP2A2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.0369483049999E-13 |
| Normal-vs-Stage2 |
3.044100E-04 |
| Normal-vs-Stage3 |
3.846800E-04 |
| Normal-vs-Stage4 |
3.177700E-02 |
| Stage1-vs-Stage2 |
9.199000E-01 |
| Stage1-vs-Stage3 |
6.436200E-01 |
| Stage1-vs-Stage4 |
9.543000E-01 |
| Stage2-vs-Stage3 |
8.018200E-01 |
| Stage2-vs-Stage4 |
9.880200E-01 |
| Stage3-vs-Stage4 |
8.426200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.69600000102344E-08 |
| Normal-vs-Asian |
1.295620E-01 |
| Caucasian-vs-AfricanAmerican |
9.478600E-01 |
| Caucasian-vs-Asian |
7.184800E-01 |
| AfricanAmerican-vs-Asian |
7.464200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
2.76809686283741E-11 |
| Male-vs-Female |
3.574800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.81759999998243E-06 |
| Normal-vs-Extreme_Weight |
6.76529998688835E-09 |
| Normal-vs-Obese |
2.4992999891893E-09 |
| Normal-vs-Extreme_Obese |
1.839020E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.780200E-01 |
| Normal_Weight-vs-Obese |
4.878600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.884950E-01 |
| Extreme_Weight-vs-Obese |
6.623800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.838400E-01 |
| Obese-vs-Extreme_Obese |
9.256100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.18870000004523E-06 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
6.08509909127974E-11 |
| Normal-vs-Age(81-100Yrs) |
2.578300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.506150E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.857500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.172200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.503800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.266200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.065400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
1.081940E-03 |
| Normal-VS-KIRP CIMP |
1.737630E-02 |
| Normal-VS-Unclassified PRCC |
2.29829999999209E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.83569999998323E-06 |
| Type1 PRCC-VS-KIRP CIMP |
6.579200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.540200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.506030E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.528500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.988400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.8523000000017E-05 |
| Normal-vs-N1 |
5.438100E-04 |
| Normal-vs-N2 |
8.067800E-02 |
| N0-vs-N1 |
1.918410E-01 |
| N0-vs-N2 |
1.596440E-01 |
| N1-vs-N2 |
5.298000E-01 |
|
|
